A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated wi

A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated wi

Item

http://www.wikidata.org/entity/Q43816422

Q43816422

about

Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function PPARs and the cardiovascular system Fatty old hearts: role of cardiac lipotoxicity in age-related cardiomyopathy PPARs: Protectors or Opponents of Myocardial Function?Mitochondrial dysfunction in diabetic cardiomyopathy Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin Tissue-specific expression of monocarboxylate transporters during fasting in mice.Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?Differential regulation of the expressions of the PGC-1α splice variants, lipins, and PPARα in heart compared to liver.The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats.Improvement of mechanical heart function by trimetazidine in db/db mice.Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia.Involvement of peroxisome proliferator-activated receptors in cardiac and vascular remodeling in a novel minipig model of insulin resistance and atherosclerosis induced by consumption of a high-fat/cholesterol diet.Cardiac function and disease: emerging role of small ubiquitin-related modifier.PPAR-alpha effects on the heart and other vascular tissues.KLF15 and PPARα Cooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation.Fatty acid synthase modulates homeostatic responses to myocardial stress.A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis.Kruppel-like factors in muscle health and disease.Expression of PPARalpha modifies fatty acid effects on insulin secretion in uncoupling protein-2 knockout mice.Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects Mitochondrial energy metabolism in heart failure: a question of balance.TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice.Phthalate exposure changes the metabolic profile of cardiac muscle cells.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function.The PPARalpha-PGC-1alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium.Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.Peroxisome proliferator-activated receptor alpha protects renal tubular cells from gentamicin-induced apoptosis via upregulating Na(+)/H(+) exchanger NHE1.Insulin resistance: metabolic mechanisms and consequences in the heart.Metabolic dysfunction in diabetic cardiomyopathy.Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function PPARalpha-mediated remodeling of repolarizing voltage-gated K+ (Kv) channels in a mouse model of metabolic cardiomyopathy.Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα.The malonyl CoA axis as a potential target for treating ischaemic heart disease.Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats The Randle cycle revisited: a new head for an old hat.

P2860

Q24621162-70B5B7BF-4F13-496A-975F-E7FE08BDA399 Q24642728-050CF11C-4189-4643-B86D-50D72BA7C981 Q26739009-201BAE02-370D-46C5-B5B3-B4A69D3AD1CD Q26771753-29A6C180-4C6D-42D4-A3D1-7983D8394FDC Q28390863-6595F47C-85B0-45D6-9F88-976DDAAFDBD7 Q28574224-54FFA383-ED82-4881-B8C8-ABA61EFEE367 Q30316982-628A0BF7-C012-4722-8FAE-5964D77B2EFC Q30353176-E074C579-5179-4348-9100-E35990B5C758 Q30412828-7B62EE3A-ED0A-454C-B7B8-46EB129878A0 Q33552642-8F4DD2BC-6C87-4ABE-9984-8897E60CCBB6 Q33717198-F9BD85EC-EFFE-4A38-956E-5153CF89A48A Q34193904-1BC2479D-BD1D-4663-BCC7-CA4CC26B4AC5 Q34405039-E79E1207-B842-44AF-BF23-BC2CEC290F7F Q34431401-34BCD663-C2A2-4516-9196-B648542FA8CA Q34988827-1D708F8C-7FC8-4960-A275-3D18D582C35A Q35032636-34927905-F7D4-4218-B9AC-AFEBCB4CB9C4 Q35080447-49511D70-3172-40C3-B40C-C3BD5C721681 Q35169996-D6E63AB9-4746-4C19-9C15-747297291EC9 Q35183031-9A510940-0899-45DD-8536-F489C237F23E Q35222107-58EE9B62-C688-483B-8544-7D3F44EFF738 Q35575864-7874CD56-486F-44EC-9C12-6A366E0C676A Q35688480-869D1F0A-02BF-4DBA-B37F-753CCAA03968 Q35803521-864EA7F4-C84D-4958-84C5-8B652F4974D4 Q36013059-55F24518-9259-4930-8D5E-CF31B77BF3C4 Q36070074-108F5F31-32D2-43E1-9D24-197387ADE334 Q36106449-969B45C9-FC97-4367-9D33-7A5997A02C52 Q36229241-6BFCAA1F-AD99-457E-8A26-7597B1F6B1AA Q36261125-B1D99437-2B5F-4DDB-B064-47DB1EF6E8E8 Q36350915-4CBC770B-47BD-436A-90F1-67B7C0CE46F0 Q36426768-AE8F2B0A-7E9C-415B-BCA4-8A3FB68EF836 Q36605039-EEE0E5BF-A697-4559-9182-1B0ADEEFDCD7 Q36758006-58DD361F-10BC-46B8-9003-08FC83140F62 Q36821424-0D537979-9040-4DF7-823D-67FCE05B71EB Q36930481-71AEA7AA-3B00-43E6-BC58-49912C36BB99 Q36950315-B49528E5-66D7-482C-AEF6-41AC504FC061 Q36961179-D2F413F1-EFD3-4CCA-83AD-5FB52EEE023B Q37054050-ED0D84EA-42F0-4BD8-A629-11075C093659 Q37171491-A3FA3346-CD17-4F8B-929D-22F7DAE80BB2 Q37294679-0CB49411-B87D-46D2-8E95-1E57E3B5634F Q37337283-31DFBDD5-1121-4AB7-99EB-8305DF4E78B4

P2860

A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated wi

Item

http://www.wikidata.org/entity/Q43816422

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

A role for peroxisome prolifer ...... ng PPARalpha are associated wi

@en

A role for peroxisome proliferator-activated receptor alpha

@nl

type

Item

label

A role for peroxisome prolifer ...... ng PPARalpha are associated wi

@en

A role for peroxisome proliferator-activated receptor alpha

@nl

prefLabel

A role for peroxisome prolifer ...... ng PPARalpha are associated wi

@en

A role for peroxisome proliferator-activated receptor alpha

@nl

P1476

A role for peroxisome prolifer ...... ng PPARalpha are associated wi

@en

P2093

Alese Wagner

http://www.w3.org/2001/XMLSchema#string

Daniel P Kelly

http://www.w3.org/2001/XMLSchema#string

Darrell D Belke

http://www.w3.org/2001/XMLSchema#string

David L Severson

http://www.w3.org/2001/XMLSchema#string

Fiona M Campbell

http://www.w3.org/2001/XMLSchema#string

Gary D Lopaschuk

http://www.w3.org/2001/XMLSchema#string

Jason R B Dyck

http://www.w3.org/2001/XMLSchema#string

Judith Y Altarejos

http://www.w3.org/2001/XMLSchema#string

Ray Kozak

http://www.w3.org/2001/XMLSchema#string

P2860

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma.

Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Ibeta gene promoters by fatty acid enzyme substrate.

AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform.

P304

4098-4103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M106054200

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11734553

http://www.w3.org/2001/XMLSchema#string

P921

fatty acid

A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated wi

about

P2860

P2860

A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated wi

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921